SOL J BARER Insider Trading $NEXI NexImmune, Inc.
Get free email notifications about insider trading for SOL J BARER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SOL J BARER. SOL J BARER is Chief Operating Officer in CELGENE CORP /DE/ ($CELG) and Director in TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA) and Director in AMICUS THERAPEUTICS INC ($FOLD) and Director in MEDGENICS, INC. ($MDGN) and Director in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in InspireMD, Inc. ($NSPR) and Director in CONTRAFECT Corp ($CFRX) and Director in NexImmune, Inc. ($NEXI) and Director in Cerecor Inc. ($CERC).
SOL J BARER in NexImmune, Inc.
Trading Symbol: NEXIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SOL J BARER: Director
Holdings: 1,367,814 shares
Latest Transaction: Feb 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SOL J BARER in NexImmune, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, GNMX, FOLD, CELG, CERC, CFRX, NSPR, NEXI, EDGE, TEVA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 217,570 | 0 | 0 | |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 82,204 | 0 | 0 | |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 164,408 | 0 | 0 | |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 894,036 | 0 | 0 | |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 800,182 | 0 | 0 | |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 217,570 | 0 | 346,577 | 129 K to 346.6 K (+168.65 %) |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | P | 17.00 | 60,000 | 1,020,000 | 1,538,013 | 1.5 M to 1.5 M (+4.06 %) |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 337,365 | 0 | 1,478,013 | 1.1 M to 1.5 M (+29.58 %) |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 82,204 | 0 | 1,140,648 | 1.1 M to 1.1 M (+7.77 %) |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 164,408 | 0 | 1,058,444 | 894 K to 1.1 M (+18.39 %) |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 894,036 | 0 | 894,036 | 0 to 894 K |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 800,182 | 0 | 1,367,814 | 567.6 K to 1.4 M (+140.97 %) |
Feb 16 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | A | 17.00 | 19,113 | 324,921 | 225,013 |
Page: 1